Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort

被引：0
|
作者：
Pamela L. Horn-Ross
Alison J. Canchola
Leslie Bernstein
Susan L. Neuhausen
David O. Nelson
Peggy Reynolds
机构：
[1] Cancer Prevention Institute of California,Department of Population Sciences
[2] Cancer Prevention Institute of California,Division of Epidemiology, Department of Health Research and Policy
[3] Beckman Research Institute,undefined
[4] City of Hope,undefined
[5] Stanford University School of Medicine,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Breast cancer; Body size; Obesity; Adiposity; Body fat distribution; Height; Life course;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence
    Yongmei Wang
    Fanbo Jing
    Haibo Wang
    Advances in Therapy, 2022, 39 : 862 - 891
  • [32] Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy
    Kumeta, Toko
    Matsunuma, Ryoichi
    Yamaguchi, Kei
    Hayami, Ryosuke
    Tsuneizumi, Michiko
    CASE REPORTS IN ONCOLOGY, 2019, 12 (03): : 814 - 819
  • [33] Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence
    Wang, Yongmei
    Jing, Fanbo
    Wang, Haibo
    ADVANCES IN THERAPY, 2022, 39 (02) : 862 - 891
  • [34] Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan
    Iwasaki, Motoki
    Otani, Tetsuya
    Inoue, Manami
    Sasazuki, Shizuka
    Tsugane, Shoichiro
    ANNALS OF EPIDEMIOLOGY, 2007, 17 (04) : 304 - 312
  • [35] WHY ARE ESTROGEN-RECEPTOR-NEGATIVE BREAST CANCERS MORE AGGRESSIVE THAN THE ESTROGEN-RECEPTOR-POSITIVE BREAST CANCERS
    SHEIKH, MS
    GARCIA, M
    PUJOL, P
    FONTANA, JA
    ROCHEFORT, H
    INVASION & METASTASIS, 1994, 14 (1-6): : 329 - 336
  • [36] Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort
    Joan A. Largent
    Leslie Bernstein
    Pamela L. Horn-Ross
    Sarah F. Marshall
    Susan Neuhausen
    Peggy Reynolds
    Giske Ursin
    Jason A. Zell
    Argyrios Ziogas
    Hoda Anton-Culver
    Cancer Causes & Control, 2010, 21 : 1615 - 1624
  • [37] Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort
    Largent, Joan A.
    Bernstein, Leslie
    Horn-Ross, Pamela L.
    Marshall, Sarah F.
    Neuhausen, Susan
    Reynolds, Peggy
    Ursin, Giske
    Zell, Jason A.
    Ziogas, Argyrios
    Anton-Culver, Hoda
    CANCER CAUSES & CONTROL, 2010, 21 (10) : 1615 - 1624
  • [38] Risk factors for estrogen receptor positive and estrogen receptor negative breast cancer.
    Rosner, BA
    Colditz, GA
    Chen, WY
    Holmes, MD
    Hankinson, SE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S40 - S40
  • [39] Estrogen-Receptor Loss and ESR1 Mutation in Estrogen-Receptor-Positive Metastatic Breast Cancer and the Effect on Overall Survival
    Westenend, Pieter J.
    Meurs, Claudia J. C.
    de Leeuw, Bertie
    Akkers, Robert C.
    CANCERS, 2024, 16 (17)
  • [40] ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
    Guotai Xu
    Sagar Chhangawala
    Emiliano Cocco
    Pedram Razavi
    Yanyan Cai
    Jordan E Otto
    Lorenzo Ferrando
    Pier Selenica
    Erik Ladewig
    Carmen Chan
    Arnaud Da Cruz Paula
    Matthew Witkin
    Yuanming Cheng
    Jane Park
    Cristian Serna-Tamayo
    HuiYong Zhao
    Fan Wu
    Mirna Sallaku
    Xuan Qu
    Alison Zhao
    Clayton K Collings
    Andrew R. D’Avino
    Komal Jhaveri
    Richard Koche
    Ross L. Levine
    Jorge S. Reis-Filho
    Cigall Kadoch
    Maurizio Scaltriti
    Christina S. Leslie
    José Baselga
    Eneda Toska
    Nature Genetics, 2020, 52 : 198 - 207
12345